000 01426 a2200361 4500
005 20250511195716.0
264 0 _c19911101
008 199111s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI115408
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBritigan, B E
245 0 0 _aPseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cOct 1991
300 _a1092-102 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aApoproteins
_xmetabolism
650 0 4 _aBinding Sites
650 0 4 _aEndopeptidases
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHydroxides
_xmetabolism
650 0 4 _aHydroxyl Radical
650 0 4 _aHypochlorous Acid
_xpharmacology
650 0 4 _aLactoferrin
_xmetabolism
650 0 4 _aLeukocyte Elastase
650 0 4 _aNeutrophils
_xphysiology
650 0 4 _aPancreatic Elastase
_xpharmacology
650 0 4 _aPseudomonas
_xenzymology
650 0 4 _aTransferrin
_xmetabolism
700 1 _aEdeker, B L
773 0 _tThe Journal of clinical investigation
_gvol. 88
_gno. 4
_gp. 1092-102
856 4 0 _uhttps://doi.org/10.1172/JCI115408
_zAvailable from publisher's website
999 _c1662304
_d1662304